Matinas BioPharma Holdings, Inc. (MTNB)
NYSEAMERICAN: MTNB · Real-Time Price · USD
0.580
+0.040 (7.39%)
Nov 21, 2024, 4:00 PM EST - Market closed
MTNB Cash Flow Statement
Financials in millions USD. Fiscal year is January - December.
Millions USD. Fiscal year is Jan - Dec.
| TTM
| FY 2023 | FY 2022 | FY 2021 | FY 2020 | FY 2019 |
| Sep '24 Sep 30, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 | Dec '20 Dec 31, 2020 | Dec '19 Dec 31, 2019 |
| Net Income | -21.13 | -22.94 | -21 | -23.28 | -22.45 | -17.37 | |
| Depreciation & Amortization | 0.97 | 0.94 | 0.9 | 0.78 | 0.77 | 0.78 | |
| Other Amortization | 0 | 0.11 | 0.21 | 0.25 | 0.24 | 0 | |
| Loss (Gain) From Sale of Assets | 0 | 0 | 0 | 0 | - | 0.01 | |
| Loss (Gain) From Sale of Investments | - | - | - | - | 0.01 | - | |
| Stock-Based Compensation | 4.22 | 4.95 | 5.23 | 4.29 | 4.56 | 2.99 | |
| Other Operating Activities | - | - | 0.29 | 1.2 | - | - | |
| Change in Accounts Payable | -0.49 | -0.1 | -0.32 | 0.59 | -0.33 | 0.38 | |
| Change in Other Net Operating Assets | -0.53 | 1.77 | -4.47 | 0.95 | -0.18 | -0.88 | |
| Operating Cash Flow | -16.95 | -15.28 | -19.16 | -15.22 | -17.37 | -14.09 | |
| Capital Expenditures | - | -0.22 | -0.89 | -0.26 | -0.01 | -0.41 | |
| Investment in Securities | 11.67 | 13.46 | 5.77 | 17.03 | -40.66 | -5.61 | |
| Investing Cash Flow | 11.67 | 13.24 | 4.88 | 16.77 | -40.67 | -6.01 | |
| Short-Term Debt Repaid | - | - | - | - | - | -0.2 | |
| Long-Term Debt Repaid | - | -0.01 | -0.02 | -0.03 | -0.05 | -0.08 | |
| Total Debt Repaid | -0.01 | -0.01 | -0.02 | -0.03 | -0.05 | -0.28 | |
| Net Debt Issued (Repaid) | -0.01 | -0.01 | -0.02 | -0.03 | -0.05 | -0.28 | |
| Issuance of Common Stock | 9.18 | - | 0.1 | 7 | 48.1 | 30.13 | |
| Financing Cash Flow | 9.17 | -0.01 | 0.08 | 6.97 | 48.05 | 29.85 | |
| Net Cash Flow | 3.89 | -2.04 | -14.2 | 8.51 | -9.99 | 9.75 | |
| Free Cash Flow | -16.95 | -15.5 | -20.05 | -15.48 | -17.37 | -14.5 | |
| Free Cash Flow Margin | - | -1413.87% | -628.86% | -46918.18% | -10972.81% | -16142.24% | |
| Free Cash Flow Per Share | -3.62 | -3.57 | -4.62 | -3.68 | -4.41 | -4.99 | |
| Levered Free Cash Flow | -8.22 | -6.85 | -14.39 | -8.25 | -9.76 | -9.92 | |
| Unlevered Free Cash Flow | -8.22 | -6.96 | -14.6 | -8.5 | -10 | -9.91 | |
| Change in Net Working Capital | 0.38 | -2.23 | 4.47 | -2.15 | 0.2 | 1.45 | |
Source: S&P Capital IQ. Standard template.
Financial Sources.